Additionally, the study identified AKT1, EGFR, ALB, and TNF genes as potential targets for drug intervention, and p-cresol glucuronide, secoisolariciresinol, glycocholic acid, enterodiol, and citric acid as active inhibitors that could be effective in mitigating the risk factors associated with HCC. Here, EGFR is linked to hepatocellular carcinoma.